Carey Farquhar, MPH

Carey Farquhar practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Carey Farquhar's NPI, 1376623355, was assigned on October 16, 2006. Carey Farquhar graduated from Harvard Medical School in 1994. Carey Farquhar holds Washington license MD00033960.

Carey Farquhar's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Carey Farquhar's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Carey Farquhar to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Carey Farquhar practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Carey Farquhar's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Carey Farquhar is licensed in Washington.

CMS data shows 16 Medicare services from Carey Farquhar across 1 procedure code in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $1,033 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Carey Farquhar in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Carey Farquhar's median patient age at 52, with 35% women.

In 2024, Carey Farquhar wrote 824 Medicare Part D claims for 26 patients. 69% of them were for generic drugs. CMS names the drug for 667 of them, across 34 drugs with 11 or more claims each, at $472,550 in total drug cost. In 2023, CMS named 557 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Carey Farquhar for performance year 2024, reported through an alternative payment model (APM). Carey Farquhar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 228 papers to Carey Farquhar, published from 2002 to 2025. 2022 was the busiest year, with 16. The most frequent topics are HIV Infections, Kenya and HIV-1. Carey Farquhar has published most often in J Acquir Immune Defic Syndr. Carey Farquhar's most frequent co-authors are Alison Christina Roxby, MD, Anna Wald, MD, MPH and Connie L. Celum.

Dmand AI links Carey Farquhar to 2 clinical trials. Conditions studied include Hepatitis C, HIV Infections and Flaviviridae Infections.

Carey Farquhar graduated from Harvard Medical School in 1994.